Oral health promotion interventions on oral yeast in hospitalised and medically compromised patients: a systematic review

Lam, Olt; Bandara, Nihal; Samaranayake, LP; McGrath, Colman; Li, Leonard S.W.

doi:10.1111/j.1439-0507.2011.02062.x

Cited by 12 publications

(3 citation statements)

References 100 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In some studies, the control group was prescribed nystatin as an antifungal drug. The equivocal results observed could have been due to reduced patient compliance and increased antibiotic usage in test groups relative to control groups …”

Section: Cleansability (Table )mentioning

confidence: 92%

Patient compliance as a risk factor for the outcome of implant treatment

Cortellini

Favril

Nutte

et al. 2019

Periodontology 2000

View full text Add to dashboard Cite

dental implant, implant treatment, patient compliance, peri-implantitis | INTRODUC TI ONIt is well-established that the maintenance of healthy tissues around implants is one of the key factors in the long-term success of implants. Plaque accumulation induces an inflammatory process that may lead to a progressive destruction of soft and hard tissues and, ultimately, to implant failure. 1-3 The inflammatory process, mucositis, is a marginal inflammation without attachment or bone loss, 4 similar to gingivitis around natural teeth. The inflammatory process associated with the loss of marginal supporting bone around an implant is defined as peri-implantitis. 5,6 One problem with the diagnosis of peri-implant disease is that substantial variation in prevalence has been reported in the same patient population depending on which diagnostic criteria are used. 7The current guidelines for the definition and diagnosis of peri-implant diseases were established in the sixth, seventh, and eighth European Workshops on Periodontology. 6,8,9 The prevalence of peri-implantitis seems to be of the order of 10% at implant level and 20% at patient level during 5-10 years of function. 10 A meta-analysis reported a weighted mean prevalence of peri-implant mucositis of 43% (1196 patients and 4209 implants) and a weighted mean prevalence of peri-implantitis of 22% (2131 patients and 8893 implants).However, the authors stated that the heterogeneity in definition criteria of peri-implantitis could be a confounder.Peri-implantitis has been primarily described as a simple infectious pathologic condition of peri-implant tissues. 1,11 Many local factors, such as implant surface, topology, and bacterial contamination at the implant/abutment junction, and patient factors, such as smoking habit, poor oral hygiene, history or presence of periodontitis, genetics, and excessive alcohol consumption, have also been associated with an increased risk of developing peri-implant diseases. [12][13][14][15][16] The etiology of alveolar bone loss around implants plays a crucial role in the classification of the disease. The most common theories to explain alveolar bone loss are the infection theory and the overload theory. 17 The infection theory states that implants are susceptible to similar types of disease as teeth, the major difference being that the term periodontitis is reserved for teeth and peri-implantitis is reserved for implants. The overload theory has not been clearly determined. Some studies have suggested that Occlusal overload may play a role when associated with plaque accumulation or pre-existing inflammation. 18 A third theory has also been developed, where alveolar bone loss is explained by the synergy of combined factors, such as surgical procedures, prosthodontics, and patient disorders. 17 The difference between primary and secondary peri-implantitis has also been presented. In primary peri-implantitis, bacterial infection is the primary cause of alveolar bone loss, whereas secondary peri-implantitis may originate from other factors. 1...

show abstract

Section: Cleansability (Table )mentioning

confidence: 92%

Patient compliance as a risk factor for the outcome of implant treatment

Cortellini

Favril

Nutte

et al. 2019

Periodontology 2000

View full text Add to dashboard Cite

show abstract

“…Az Enterobacteriaceae család, Acinetobacter, Pseudomonas, Stenotrophomonas és Burkholderia a kórházban szerzett fertőzések jelentős részét képezik, beleértve a pneumoniát, a vérárami és húgyúti infekciókat [58]. A rezisztens P. aeruginosa törzsek által okozott fertőzések nagymértékű mortalitással járnak, és jelentős szerepük van a kórházi bentfekvések időtartamának, illetve az egészség-ügyi költségek növekedésében.…”

Section: Eredeti Közleményunclassified

Bakteriális infekciók májátültetés után

et al. 2015

View full text Add to dashboard Cite

Bevezetés: A szerzők a májátültetést követően kialakult mikrobás fertőzéseket, a mintavételek eredményeit, a multidrug-rezisztencia incidenciáját vizsgálták a hazai betegek körében. Célkitűzés: Tanulmányozták a bakteriális fertőzés kialakulásának kockázati tényezőit, az infekciókhoz kapcsolódó szövődmények előfordulását, lefolyását, és részletes kórokozó-spektrumelemzést végeztek. Módszer: 2003-2012 között májátültetett 408 beteg adatait (281 bakterioló-giai tenyésztést) vizsgálták. Eredmények: A 408 beteg közül 70 betegnél (17%) észleltek klinikai tünetekkel járó fertőzést. A tenyésztési lelet 58 betegnél (14,2%) pozitív, 12 betegnél (2,9%) negatív volt. Hét esetben (12,1%) alakult ki cholangitis, 17 esetben (29,3%) fordult elő hasűri és 28 esetben (48,3%) pulmonalis eredetű fertőzés. Posztoperatív fertőzés gyakrabban lépett fel kezdeti csökkent graftműködés, akut veseelégtelenség, epeúti szövődmény és hasű-ri vérzés mellett. Infekció kialakulása esetén az 1, 3 és 5 éves betegtúlélés 70%, 56% és 56% volt, míg infekció nélkül ez 94%, 87%, 85% volt (p<0,001). A kitenyészett baktériumok 56%-ánál találtak multidrug-rezisztenciát, viszont nem volt szignifi káns különbség a multidrug-rezisztencia pozitív és negatív baktériummal fertőzött csoportok egyéves betegtúlélése között (70,2% mindkettő). Következtetések: Az infekciókontroll, a multidrug-rezisztens kórokozók menedzselése a preventív, higiéniai, izolációs elvek kialakítását, betartását, valamint műtéttechnikai, transzfúziós, antibiotikus stratégiák, folyamatok fejlesztését kell, hogy megcélozza, szakmai csapatmunka keretén belül. Orv. Hetil., 2015, 156(34), 1366-1382. Kulcsszavak: májátültetés, posztoperatív fertőzés, multidrug-rezisztencia, túlélés, szepszis Bacterial infection after orthotopic liver transplantationIntroduction: The authors reviewed the prevalence of postoperative infections, the results of bacterium cultures, and the incidence of multidrug resistance in their liver transplanted patients during a period between 2003 and 2012. Aim: The aim of this study was to analyse risk factors and colonisations of bacterial infections. Method: The fi les of 408 patients (281 bacterium cultures) were reviewed. Results: Of the 408 patients 70 had a postoperative infection (17%); 58 patients (14.2%) had positive and 12 patients (2.9%) negative bacterial culture results. Cholangitis was found in 7 cases (12.1%), abdominal infection in 17 cases (29.3%), and pulmonal infection in 28 cases (48.3%). Postoperative infection was more frequent in patients with initial poor graft function, acute renal insuffi ciency, biliary complication, and in those with intraabdominal bleeding. The 1-, 3-and 5-year cumulative survival of patients who had infection was 70%, 56% and 56%, respectively, whereas the cumulative survival data of patients without infection was 94%, 87% and 85%, respectively (p<0.001). Multidrug resistance was found in 56% of the positive cultures, however, the one-year survival was not different in patients who had multidrug resistance positive and negative...

show abstract

“…Under certain circumstances Candida spp. commensals become pathogens and cause mucous membrane infections ranging from pseudomembranous candidodis and denture-induced stomatitis (Lam et al, 2012[ 21 ]; Gonsalves et al, 2007[ 15 ]; Da Costa et al, 2006[ 12 ]; Ben-Aryeh et al, 1980[ 8 ]), to life-threatening systemic diseases (Samaranayake and Yaacob, 1990[ 33 ]), particularly in immunocompromised patients with AIDS, cancer and diabetes mellitus (Seneviratne et al, 2008[ 36 ]; Edmond et al, 1999[ 13 ]).…”

Section: Introductionmentioning

confidence: 99%